vs
COLLEGIUM PHARMACEUTICAL, INC（COLL）与STURM RUGER & CO INC（RGR）财务数据对比。点击上方公司名可切换其他公司
COLLEGIUM PHARMACEUTICAL, INC的季度营收约是STURM RUGER & CO INC的1.4倍（$205.4M vs $151.1M），COLLEGIUM PHARMACEUTICAL, INC同比增速更快（12.9% vs 3.6%），COLLEGIUM PHARMACEUTICAL, INC自由现金流更多（$122.4M vs $12.3M），过去两年COLLEGIUM PHARMACEUTICAL, INC的营收复合增速更高（19.1% vs 5.1%）
Collegium制药是一家专科制药企业，专注于研发和商业化具备滥用威慑特性的创新疼痛管理疗法，主要面向美国市场，推出适用于慢性疼痛患者的缓释镇痛产品，服务覆盖基层及专科医疗领域的医护人员。
鲁格公司（Ruger）是总部位于美国康涅狄格州绍斯波特的枪械制造企业，除总部外，还在新罕布什尔州纽波特、北卡罗来纳州梅约丹以及亚利桑那州普雷斯科特设有生产工厂。公司由亚历山大·麦考密克·斯特姆与威廉·B·鲁格于1949年共同创立，自1969年起公开上市交易。
COLL vs RGR — 直观对比
营收规模更大
COLL
是对方的1.4倍
$151.1M
营收增速更快
COLL
高出9.3%
3.6%
自由现金流更多
COLL
多$110.0M
$12.3M
两年增速更快
COLL
近两年复合增速
5.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $205.4M | $151.1M |
| 净利润 | $17.0M | — |
| 毛利率 | 62.5% | 17.8% |
| 营业利润率 | 29.6% | 2.3% |
| 净利率 | 8.3% | — |
| 营收同比 | 12.9% | 3.6% |
| 净利润同比 | 35.3% | — |
| 每股收益（稀释后） | $0.48 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COLLRGR
| Q4 25 | $205.4M | $151.1M | ||
| Q3 25 | $209.4M | $126.8M | ||
| Q2 25 | $188.0M | $132.5M | ||
| Q1 25 | $177.8M | $135.7M | ||
| Q4 24 | $181.9M | $145.8M | ||
| Q3 24 | $159.3M | $122.3M | ||
| Q2 24 | $145.3M | $130.8M | ||
| Q1 24 | $144.9M | $136.8M |
净利润COLLRGR
| Q4 25 | $17.0M | — | ||
| Q3 25 | $31.5M | $1.6M | ||
| Q2 25 | $12.0M | $-17.2M | ||
| Q1 25 | $2.4M | $7.8M | ||
| Q4 24 | $12.5M | — | ||
| Q3 24 | $9.3M | $4.7M | ||
| Q2 24 | $19.6M | $8.3M | ||
| Q1 24 | $27.7M | $7.1M |
毛利率COLLRGR
| Q4 25 | 62.5% | 17.8% | ||
| Q3 25 | 61.7% | 15.1% | ||
| Q2 25 | 57.7% | 3.9% | ||
| Q1 25 | 54.8% | 22.0% | ||
| Q4 24 | 54.0% | 22.8% | ||
| Q3 24 | 60.8% | 18.5% | ||
| Q2 24 | 62.5% | 22.3% | ||
| Q1 24 | 63.1% | 21.5% |
营业利润率COLLRGR
| Q4 25 | 29.6% | 2.3% | ||
| Q3 25 | 29.7% | -2.7% | ||
| Q2 25 | 18.7% | -15.6% | ||
| Q1 25 | 12.2% | 6.2% | ||
| Q4 24 | 20.9% | 7.8% | ||
| Q3 24 | 21.9% | 3.1% | ||
| Q2 24 | 32.7% | 6.9% | ||
| Q1 24 | 34.1% | 5.5% |
净利率COLLRGR
| Q4 25 | 8.3% | — | ||
| Q3 25 | 15.0% | 1.2% | ||
| Q2 25 | 6.4% | -13.0% | ||
| Q1 25 | 1.4% | 5.7% | ||
| Q4 24 | 6.9% | — | ||
| Q3 24 | 5.9% | 3.9% | ||
| Q2 24 | 13.5% | 6.3% | ||
| Q1 24 | 19.1% | 5.2% |
每股收益（稀释后）COLLRGR
| Q4 25 | $0.48 | $0.22 | ||
| Q3 25 | $0.84 | $0.10 | ||
| Q2 25 | $0.34 | $-1.05 | ||
| Q1 25 | $0.07 | $0.46 | ||
| Q4 24 | $0.36 | $0.62 | ||
| Q3 24 | $0.27 | $0.28 | ||
| Q2 24 | $0.52 | $0.47 | ||
| Q1 24 | $0.71 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $386.7M | $92.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $301.7M | $283.8M |
| 总资产 | $1.7B | $342.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资COLLRGR
| Q4 25 | $386.7M | $92.5M | ||
| Q3 25 | $285.9M | $80.8M | ||
| Q2 25 | $222.2M | $101.4M | ||
| Q1 25 | $197.8M | $108.3M | ||
| Q4 24 | $162.8M | $105.5M | ||
| Q3 24 | $120.0M | $96.0M | ||
| Q2 24 | $271.6M | $105.6M | ||
| Q1 24 | $318.0M | $115.3M |
股东权益COLLRGR
| Q4 25 | $301.7M | $283.8M | ||
| Q3 25 | $274.8M | $279.6M | ||
| Q2 25 | $232.2M | $289.3M | ||
| Q1 25 | $234.4M | $321.5M | ||
| Q4 24 | $228.8M | $319.6M | ||
| Q3 24 | $234.3M | $314.9M | ||
| Q2 24 | $216.6M | $321.5M | ||
| Q1 24 | $222.2M | $332.0M |
总资产COLLRGR
| Q4 25 | $1.7B | $342.0M | ||
| Q3 25 | $1.6B | $342.3M | ||
| Q2 25 | $1.6B | $349.5M | ||
| Q1 25 | $1.6B | $379.0M | ||
| Q4 24 | $1.7B | $384.0M | ||
| Q3 24 | $1.6B | $373.5M | ||
| Q2 24 | $1.1B | $376.7M | ||
| Q1 24 | $1.1B | $385.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $123.0M | $15.5M |
| 自由现金流经营现金流 - 资本支出 | $122.4M | $12.3M |
| 自由现金流率自由现金流/营收 | 59.6% | 8.2% |
| 资本支出强度资本支出/营收 | 0.3% | 2.1% |
| 现金转化率经营现金流/净利润 | 7.25× | — |
| 过去12个月自由现金流最近4个季度 | $327.6M | $38.5M |
8季度趋势，按日历期对齐
经营现金流COLLRGR
| Q4 25 | $123.0M | $15.5M | ||
| Q3 25 | $78.4M | $12.9M | ||
| Q2 25 | $72.4M | $14.7M | ||
| Q1 25 | $55.4M | $11.1M | ||
| Q4 24 | $84.6M | $20.0M | ||
| Q3 24 | $-9.0M | $9.4M | ||
| Q2 24 | $67.4M | $18.7M | ||
| Q1 24 | $61.9M | $7.3M |
自由现金流COLLRGR
| Q4 25 | $122.4M | $12.3M | ||
| Q3 25 | $78.3M | $7.0M | ||
| Q2 25 | $72.4M | $9.1M | ||
| Q1 25 | $54.6M | $10.0M | ||
| Q4 24 | $84.1M | $16.4M | ||
| Q3 24 | $-9.2M | $2.6M | ||
| Q2 24 | $67.1M | $10.1M | ||
| Q1 24 | $61.4M | $5.6M |
自由现金流率COLLRGR
| Q4 25 | 59.6% | 8.2% | ||
| Q3 25 | 37.4% | 5.5% | ||
| Q2 25 | 38.5% | 6.9% | ||
| Q1 25 | 30.7% | 7.4% | ||
| Q4 24 | 46.2% | 11.2% | ||
| Q3 24 | -5.8% | 2.1% | ||
| Q2 24 | 46.2% | 7.7% | ||
| Q1 24 | 42.3% | 4.1% |
资本支出强度COLLRGR
| Q4 25 | 0.3% | 2.1% | ||
| Q3 25 | 0.1% | 4.6% | ||
| Q2 25 | 0.0% | 4.2% | ||
| Q1 25 | 0.4% | 0.8% | ||
| Q4 24 | 0.3% | 2.5% | ||
| Q3 24 | 0.2% | 5.5% | ||
| Q2 24 | 0.2% | 6.6% | ||
| Q1 24 | 0.4% | 1.3% |
现金转化率COLLRGR
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | 8.15× | ||
| Q2 25 | 6.05× | — | ||
| Q1 25 | 22.92× | 1.43× | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | 1.98× | ||
| Q2 24 | 3.44× | 2.27× | ||
| Q1 24 | 2.23× | 1.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COLL
暂无分部数据
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
